Analysis of exosome release as a cellular response to MAPK pathway inhibition

K Agarwal1, M Saji1, S M Lazaroff1

  • 1William G. Lowrie Department of Chemical and Biomolecular Engineering, Department of Chemistry, Nanoscale Science and Engineering Center for Affordable Nanoenginering of Polymeric Biomedical Devices, Department of Internal Medicine, Division of Endocrinology Diabetes and Metabolism, Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, United States.

Insights

Thyroid cancer cells release exosomes with distinct sizes. MAPK pathway inhibition affects exosome release numbers, offering insights into cancer cell communication and therapeutic targets.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Oncology

Background:

  • Exosomes are crucial for intercellular communication.
  • The MAPK signaling pathway plays a role in cancer progression.
  • Understanding exosome release mechanisms is vital for cancer research.

Purpose of the Study:

  • To investigate the impact of MAPK signaling inhibition on exosome release in thyroid cancer cells.
  • To characterize exosome size distributions and release numbers.
  • To explore the relationship between MAPK pathway activation and exosome biogenesis.

Main Methods:

  • Asymmetric flow-field flow fractionation/multi-angle light scattering (A4F/MALS) was used to measure exosome size and number.
  • Three thyroid cancer cell lines were utilized.
  • MAPK signaling pathways were inhibited using specific treatments.

Main Results:

  • Thyroid cancer cell lines release exosomes with consistent size distributions.
  • Inhibition of MAPK signaling, particularly MEK-dependent pathways, increased exosome release per cell.
  • Exosome size distribution analysis provided insights into vesicle formation mechanisms.

Conclusions:

  • MAPK signaling pathway activation influences exosome release quantity in thyroid cancer.
  • Exosome release is a context-dependent process affected by pathway inhibitors.
  • Exosome size distribution analysis is a valuable tool for understanding vesicle formation and predicting therapeutic responses.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K